首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I
【24h】

Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I

机译:仅在很高浓度的血管紧张素I下,大鼠动脉中的血管紧张素II形成才会发生

获取原文
           

摘要

Abstract —Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10?9 to 10?5 mol/L) except at high concentrations of Ang I (>10?7 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro11,d-Ala12]Ang I (10?8 to 10?5 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro11,d-Ala12]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I–induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro11,d-Ala12]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro11,d-Ala12]Ang I. These findings suggest that biochemical and [Pro11,d-Ala12]Ang I–derived results may not reflect the functional significance of chymase.
机译:摘要—与以前的报道相反,最近的酶法检测显示大鼠动脉中糜蛋白酶样活性占主导地位。我们通过测量器官浴中动脉环的收缩和清醒大鼠的血压来确定大鼠颈动脉中这种替代途径的存在和意义。仓鼠主动脉作为糜酶的阳性对照。除高浓度的Ang I(> 10?7 mol / L)外,替莫卡普利(30μmol/ L)抑制血管紧张素(Ang)I的收缩(10?9至10?5 mol / L)。替莫卡普尔中添加了促凝抑素(100μmol/ L)发挥了协同抑制作用。仓鼠主动脉给出了相似的结果,但替莫卡普利的功效比大鼠动脉低30倍。 [Pro11,d-Ala12] Ang I(10?8至10?5 mol / L),一种糜酶特异性底物,在大鼠和仓鼠动脉中引起了类似的反应。促凝抑素,但不是替莫卡普利,减弱了反应。 CV 11974(30μmol/ L),一种Ang II 1型受体拮抗剂,取消了对这两种肽的反应。在清醒的大鼠中,Ang I(0.03至30μg/ kg)和[Pro11,d-Ala12] Ang I(7至700μg/ kg)产生相似的升压反应。不仅CV 11974(1 mg / kg),而且替莫卡普利(2 mg / kg)都消除了Ang I诱导的体内反应。 CV 11974,但不是替莫卡普利,抑制了对[Pro11,d-Ala12] Ang I的反应。我们的结果显示大鼠动脉中存在替代途径,但没有发挥主要作用。具有糜酶相对特性的动脉对[Pro11,d-Ala12] Ang I的反应均等。这些发现表明,生化和[Pro11,d-Ala12] Ang I的结果可能无法反映糜酶的功能意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号